Pharmaceutical News

RSS

Grant awarded for research into a new treatment for methamphetamine addiction

Dr. Keith Flower - a research physician at the Addiction Pharmacology & Research Laboratory in San Francisco, CA - has been awarded a grant to investigate a new medication treatment for methamphetamine addiction. This grant has been awarded to California Pacific Medical Center's Research Institute through President Obama's AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009.

6 Nov 2009

Wedgewood Pharmacy announces compounding of thyroid tablets in response to physician demand

Wedgewood Pharmacy announced today that it is compounding thyroid tablets in response to physician demand during the long-term backorder of Forest Laboratories’ Armour® Thyroid tablets. Compounded using Thyroid USP powder, a naturally occurring thyroid, Wedgewood Pharmacy’s scored tablets are available by prescription in 15mg, 30mg, 60mg and 120mg, with prices ranging from $21 to $25 per 100-count bottle.

6 Nov 2009

Citracal Calcium plus Heart Health helps support bone and heart health in women

Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis-related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time.

6 Nov 2009

Physicians concern about the spread of H1N1 virus and the availability of H1N1 vaccine

According to a Panel Intelligence survey of 50 primary care physicians, there are significant concerns about the H1N1 virus not just in terms of disease prevalence and vaccine shortages, but also in that 38% of the physicians surveyed (PCPs, pediatricians, and gerontologists) are "very concerned" about the virus evolving into a more serious strain and another 52% have moderate concerns about such a development.

6 Nov 2009

Patent covering the approved administration of Kuvan with food issued

BioMarin Pharmaceutical Inc. announced today that the United States Patent and Trademark Office has issued a patent covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food for the treatment of phenylketonuria (PKU). The patent expires in 2024.

6 Nov 2009

TREANDA induces durable responses in indolent B-cell non-Hodgkin's lymphoma patients

Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.

6 Nov 2009

FDA grants orphan drug designation for Sunesis Pharmaceuticals' voreloxin

Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.

6 Nov 2009

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that widespread generic erosion of branded atypical antipsychotics will cause the bipolar disorder drug market to decline from $6.3 billion in 2008 to approximately $5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

6 Nov 2009

Quintiles opens expanded regional headquarters facility in Singapore

To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore’s Science Park I.

6 Nov 2009

ImmunoLin provides immediate benefit to the function of immune system and gut

A new study provides evidence that ImmunoLin®, an all natural and GRAS approved source of immunoglobulin, will provide immediate benefit to the function of the immune system and the gut. Immunoglobulins, or antibodies, are specialized proteins found in blood that the immune system naturally produces for immunity.

6 Nov 2009

Wide gap between perceived and real determinants of antibiotic prescription exists, says researcher

Antibiotic over-prescription is promoted by pediatricians' perception of parents' expectations. Research published in the open access journal BMC Pediatrics shows that pediatricians are more likely to inappropriately prescribe antibiotics for respiratory tract infections if they perceived parents were expecting a prescription.

6 Nov 2009

Pfizer extends JAK3 research collaboration with Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated announced today that its research collaboration with Pfizer for JAK3 has been extended by one year. The Research and License Agreement entered into in December 2006 with Wyeth provided for an initial three year research term. Under this extension, Ligand will receive $3.1 million in research payments to continue conducting drug discovery and lead candidate optimization.

6 Nov 2009

USPTO issues Notice of Allowance to NovaDel Pharma

NovaDel Pharma Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715, entitled “Buccal, Polar and Non-polar Spray Containing Zolpidem,” which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaMist™ Oral Spray spray technology.

6 Nov 2009

Medtipster announces new promotion to help Michigan residents save on their prescription costs

Medtipster, the company behind the new online healthcare search engine and price comparator Medtipster.com, is pleased to announce a new promotion to help Michigan residents save on their prescription costs.

6 Nov 2009

Unum enhances the wellness benefit of its critical illness products by adding H1N1 vaccine

Unum has enhanced the wellness benefit of its critical illness products by adding the H1N1 vaccine to the list of qualifying procedures.

6 Nov 2009

DSM Pharmaceutical Products announces manufacturing alliance with Galenix

DSM Pharmaceutical Products today announced that it has made a manufacturing alliance with Galenix, Saint Jean D'Illac, France, where DSM will be the preferred commercial scale manufacturing partner for Galenix commercial products on a global basis.

6 Nov 2009

New FDA program targets drug dosage errors

Federal Drug Administration Commissioner Margaret A. Hamburg announced a new "Safe Use" program for drugs on Wednesday.

6 Nov 2009

Walls Street journal examines big pharma's 'growing interest' in emerging-market vaccine development, production

The Wall Street Journal examines "big pharma's growing interest in a corner of healthcare - emerging-market inoculations," in light of a recent move by Novartis to purchase an 85 percent stake in the Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical Co. In the summer, drug maker Sanofi-Aventis SA made a similar move to acquire a majority stake in India's Shantha Biotechnics, the newspaper notes.

6 Nov 2009

DOJ investigates alleged fraud by drugmakers; sanctions on wellcare lifted

"A $112 million settlement involving alleged drug kickbacks that the Justice Dept. announced with the nation's largest nursing home pharmacy and a generic drug manufacturer on Nov. 3 is part of a wide-ranging investigation of suspected Medicaid fraud by the pharmaceutical industry," Business Week reports. "Critics say the continuing probe, which involves Johnson & Johnson (JNJ) and other major drugmakers, highlights what they describe as an industry practice of paying money to outfits that provide drugs to consumers, in return for preferential treatment."

6 Nov 2009

FDA: Sexual enhancement product "Stiff Nights" can dangerously lower blood pressure and is illegal

The U.S. Food and Drug Administration is warning consumers that Stiff Nights, a product marketed as a dietary supplement for sexual enhancement, contains an ingredient that can dangerously lower blood pressure and is illegal.

6 Nov 2009

Pharmaceutical News

Grant awarded for research into a new treatment for methamphetamine addiction

Wedgewood Pharmacy announces compounding of thyroid tablets in response to physician demand

Citracal Calcium plus Heart Health helps support bone and heart health in women

Physicians concern about the spread of H1N1 virus and the availability of H1N1 vaccine

Patent covering the approved administration of Kuvan with food issued

TREANDA induces durable responses in indolent B-cell non-Hodgkin's lymphoma patients

FDA grants orphan drug designation for Sunesis Pharmaceuticals' voreloxin

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Quintiles opens expanded regional headquarters facility in Singapore

ImmunoLin provides immediate benefit to the function of immune system and gut

Wide gap between perceived and real determinants of antibiotic prescription exists, says researcher

Pfizer extends JAK3 research collaboration with Ligand Pharmaceuticals

USPTO issues Notice of Allowance to NovaDel Pharma

Medtipster announces new promotion to help Michigan residents save on their prescription costs

Unum enhances the wellness benefit of its critical illness products by adding H1N1 vaccine

DSM Pharmaceutical Products announces manufacturing alliance with Galenix

New FDA program targets drug dosage errors

Walls Street journal examines big pharma's 'growing interest' in emerging-market vaccine development, production

DOJ investigates alleged fraud by drugmakers; sanctions on wellcare lifted

FDA: Sexual enhancement product "Stiff Nights" can dangerously lower blood pressure and is illegal

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News